They have also been proven to be a highly effective treatment for baby colic, significantly reducing average daily crying time and even show a prophylactic effect.
The first such study, published in the medical journal Pediatrics (2007 ), showed that after 28 days of treatment with BioGaia® Drops average crying time for colicky babies had decreased from 159 minutes to only 51 minutes, and that fully 95% of babies in the study showed marked improvements in crying time. In 2012 another study also published in the journal of Pediatrics showed a decrease in crying time of 56%! BioGaia® Drops contributed not only to babies' comfort and happiness, but also to the harmony of the entire family.
A just released study of 468 healthy newborns shows that infants given the probiotic BioGaia® (Limosilactobacillus reuteri Protectis® /TM) cried less than half as long as infants given a placebo. The infants given BioGaia® drops also had significantly fewer daily regurgitations and were less constipated compared to infants in the placebo group. As a result, the use of BioGaia® drops proved to be cost saving for both parents and the community. Get an overview of all studies with BioGaia® (Limosilactobacillus reuteri Protectis®) proven effective for colicky babies.
Containing Limosilactobacillus reuteri Protectis®, BioGaia® Pobiotic Drops promote the growth of good bacteria in the infant’s intestinal tract, re-establishing a healthy bacterial balance and thus significantly reduce the average daily crying time and even show a prophylactic effect in avoiding colic, constipation and regurgitation.
drops daily for at least 4 weeks – or ideally from the first day of life!
Limosilactobacillus reuteri ATCC 55730 versus Simethicone in the Treatment of Infantile Colic
Savino, Pelle, Oggero. J Pediatr 2007;119:e124-e130
Limosilactobacillus reuteri DSM 17938 for the Management of Inf antile Colic in Breastfed Infants.
Szajewska, Gyrczuk, Horvath. J Pediatr 2013;162:257-262.
Significant improved family quality of life with BioGaia®.
Act and not React: Prophylactic use of a Probiotic in the Prevention of Colic, Regurgitation and Functional Constipation.
Indrio et al. JAMA Pediatr. JAMA Pediatr.
Published online January 13, 2014. doi:10.1001/jamapediatrics.2013.4367
Less, crying, less regurgitation, less constipation…
The study was a placebo-controlled, double blind, multicentre trial performed in nine neonatology units in Italy. 589 patients were randomly allocated to receive 1x108cfu of the probiotic Limosilactobacillus reuteri Protectis® (BioGaia® drops) or placebo daily for 90 days. Of these 468 infants completed study, 238 in the Limosilactobacillus reuteri Protectis® group and 230 in the placebo group. All included infants were healthy at study start.